CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog & Media
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Cecily Strong to Host Cancer Research Institute’s 2024 Annual Awards Gala

    On Tuesday, October 15, 2024, the Cancer Research Institute (CRI) will pay tribute to 71 years of…
    September 19, 2024| Max Mallet
  • CICON24 Recap: Key Breakthroughs and Bold Conversations Shaping the Future of Immunotherapy

    The Cancer Immunotherapy Conference (CICON24) opened with a palpable sense of urgency and optimism, bringing together the…
    September 17, 2024| Ajit Muley, PhD
  • National Hispanic Heritage Month: Honoring Contributions in Immunotherapy

    Immunotherapy is a personalized, powerful, and predictable treatment that holds immense progress and potential against cancer. This…
    September 17, 2024| Max Mallet
  • Ovarian Cancer Awareness Month: How Immunotherapy Fights This High-Occurrence Malignancy

    Ovarian cancer is one of several gynecologic malignancies, impacting about 300,000 women globally each year. September has…
    September 13, 2024| Max Mallet
  • 5 Things to Know if You Missed CICON24

    CICON24 wrapped up on September 11, 2024, at the Gaylord National Resort and Convention Center in National…
    September 13, 2024| Ajit Muley, PhD
  • Supercharging T Cells to Fight Cancer: A Revolutionary Discovery

    In the battle against cancer, our immune system’s T cells are frontline soldiers, designed to seek out…
    September 13, 2024| Ajit Muley, PhD
  • CICON24 Day 4 Recap: Pioneering Cellular Therapies and Cancer Vaccines Shape the Future of Cancer Treatment

    Led by inaugural CRI Lloyd J. Old STAR, Yvonne Chen, PhD, from UCLA, day four of CICON24…
    September 11, 2024| Ajit Muley, PhD
  • CICON24 Day 3 Recap: Advances in T Cell Tolerance, Metabolism, and the Microbiome in Cancer Immunotherapy

    Day three of CICON24 continued the momentum of the previous days with an impressive lineup of talks…
    September 10, 2024| Ajit Muley, PhD
  • CICON24 Day 2 Recap: Exploring Cancer Vaccines, Immune Health, and Future Therapies 

    NATIONAL HARBOR —Day two of CICON24 began with an impactful keynote by Cathy Wu, MD, from Dana…
    September 9, 2024| Ajit Muley, PhD
Previous Page
1 2 3 4 5 … 20
Next Page
CRI Logo

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog & Media
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute